
KARIMA OUALLA
MD, MSc
Fez, Morocco
Karima Oualla, MD, MSc – Associate Professor of Medical Oncology, Faculty of Medicine and Pharmacy, University Sidi Mohamed Ben Abdellah, Fez, Morocco Referent on GU cancers Hassan II University Hospital – Morocco . Council member of the Global Society of Rare Genitourinary Tumors (GSRGT). Joint committee International Bladder Cancer Group IBCG-GSRGT. Dr Oualla completed her medical training at University Sidi Mohamed Ben Abdellah prior to practicing as a Medical Oncologist at Hassan II University Hospital. She also earned a degree in epidemiology and clinical research from University Sidi Mohamed Ben Abdellah then joined Institut Jules Bordet in Brussels, Belgium, as an assistant doctor (2012–2013). Dr Oualla holds a certificate of specialization in Medical Oncology from the Université Libre de Bruxelles, and completed a 3-year postgraduate course in Medical Oncology (European Organisation for Research and Treatment of Cancer [EORTC]-affiliated National Belgian Programme for Inter-University Faculty). Dr Oualla was awarded a fellowship by the European Society of Medical Oncology (ESMO) on Onco-Urology at the Istituto Nazionale dei Tumori, in Milan, Italy where she worked in Onco-Urology Unit. In 2015, she joined the Cancer Prevention and Control Research Training Programme at the Department of Public Health in the University of South Florida, in Tampa, FL, USA, funded by the National Institutes of Health (NIH) Fogarty International Center, Bethesda, MD, USA, and Moffitt Cancer Center, Tampa (2015–2016), where she graduated on “Concepts and Tools of Epidemiology”. In 2016, Dr Oualla undertook transitional research training at the Comprehensive Cancer Center (CCC), in Vienna, Austria, and completed an ESMO fellowship in the Palliative Care Department at the Centre Léon Bérard, in Lyon, France, in 2019.She completed a master’s degree in Science at Ulm University, in Ulm, Germany in 2020. Dr Oualla was designated as an ambassador of the European School of Oncology for the years 2023 and 2024. Dr Oualla serves on the leadership Council of the Global Society of Rare Genitourinary Tumors (GSRGT), and the scientific committee of the International Bladder Cancer Group (IBCG). She is also member of ESMO, the American Society of Clinical Oncology (ASCO), the European School of Oncology (ESO).


